Zoetis (ZTS) Current Assets (2012 - 2026)
Zoetis (ZTS) posted quarterly Current Assets of $6.5 billion for Q1 2026, up 10.16% year-over-year from $5.9 billion in Q1 2025, and down 4.41% quarter-over-quarter from $6.8 billion in Q4 2025.
Zoetis (ZTS) Current Assets (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Current Assets for 15 consecutive years, with $6.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 10.16% year-over-year to $6.5 billion; the TTM figure through Mar 2026 stood at $6.5 billion (up 10.16% YoY), while the FY2025 annual figure was $6.8 billion, up 13.15% from the prior year.
- Current Assets retreated to $6.5 billion in Q1 2026 per ZTS's latest filing, from $6.8 billion in the prior quarter.
- Across five years, Current Assets topped out at $7.5 billion in Q4 2022 and bottomed at $5.9 billion in Q1 2025.
- Historically, Current Assets has averaged $6.4 billion across 5 years, with a median of $6.3 billion in 2023.
- Annual changes were most pronounced in 2023 — Current Assets retreated 15.49% — and 2025, when it grew 13.15%.
- Zoetis' Current Assets stood at $7.5 billion in 2022, then declined by 15.49% to $6.3 billion in 2023, then dropped by 5.63% to $6.0 billion in 2024, then rose by 13.15% to $6.8 billion in 2025, then decreased by 4.41% to $6.5 billion in 2026.
- Business Quant data shows ZTS's Current Assets at $6.5 billion in Q1 2026, $6.8 billion in Q4 2025, and $6.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.36 Bn |
| Mar 31, 2026 | 6.47 Bn |
| Dec 31, 2025 | 6.77 Bn |
| Sep 30, 2025 | 6.58 Bn |
| Jun 30, 2025 | 5.92 Bn |
| Mar 31, 2025 | 5.88 Bn |
| Dec 31, 2024 | 5.99 Bn |
| Sep 30, 2024 | 6.28 Bn |
| Jun 30, 2024 | 6.20 Bn |
| Mar 31, 2024 | 6.36 Bn |
| Dec 31, 2023 | 6.34 Bn |
| Sep 30, 2023 | 6.22 Bn |
| Jun 30, 2023 | 6.18 Bn |
| Mar 31, 2023 | 6.27 Bn |
| Dec 31, 2022 | 7.51 Bn |
| Sep 30, 2022 | 6.55 Bn |
| Jun 30, 2022 | 6.65 Bn |
| Mar 31, 2022 | 6.84 Bn |
| Dec 31, 2021 | 6.93 Bn |
| Sep 30, 2021 | 6.68 Bn |